The future of COVID-19 vaccines On the day the world recovers from the epidemic
Arrival of COVID-19 Changed this world until now People still wear masks. Online learning and working from home formats are becoming more popular. Carrying alcohol gel or spray has become commonplace. However, one thing that is being talked about less and less is the COVID-19 vaccination. If we go back to the beginning of the outbreak. Vaccines are the hope of humanity who wants to be able to live a normal life again. But at present People no longer need to get vaccinated. Here, Thantasart would like to take readers to explore the current status of COVID-19 vaccines and the future direction as follows. [1, 2, 3, 4]
When the COVID-19 vaccine It’s not as much of a necessity as in the past. Vaccine companies’ stocks have continued to fall, with Pfizer’s shares at their lowest in 10 years. This year, the company posted revenue of between $58 and $61 billion. Even though from the beginning in 2022 the company had revenues exceeding 100 billion US dollars. Meanwhile Other vaccine companies, such as Moderna, have seen their revenues plummet and have begun looking at plans to scale up their vaccine production facilities. These possibilities are things that the company has already anticipated. As the spread of COVID-19 decreases, vaccines will also be less in demand.
However, even though the epidemic has subsided, COVID-19 has not yet disappeared from the world. New species may emerge at any time. And these pharmaceutical companies may still play a role in producing vaccines to meet people’s needs. But even a vaccine may still be in demand. COVID-19 vaccine production To be consistent with emerging species is still full of many limitations. Because vaccine production has many steps. Including finding volunteers for human testing, finding funding, sponsors, and even producing new vaccines. Covid strains may also evolve so that the vaccines that have advanced can’t keep up with the new strains.
Moreover, today, COVID-19 is no longer an urgent disease that people fear. New epidemics that are likely to occur Including old illnesses that may have different effects on people’s health. Whether it’s different strains of influenza, dengue fever, cancer, and so much more, companies that have flourished with COVID-19 vaccines Therefore began to turn to focus on other types of medicine. and may not be dedicated to developing a COVID-19 vaccine equivalent to the past period
Although nowadays COVID-19 vaccine will be much less in demand But we cannot forget that the continuous development of these companies has helped save many lives during the COVID-19 outbreak. and contributed to returning the world to the peaceful state it is in today. From now on, we can only wait and see how these companies will continue to grow and what COVID-19 will hold in the future.
Investing Science – Investerest
Follow good articles by clicking here. FACEBOOK and WEBSITE
refer
[1] Bill McColl. (December 13, 2023). Pfizer Shares Dropped to Their Lowest Level in Over 10 Years—Here’s Why. Retrieved from https://www.investopedia.com/pfizer-shares-dropped-to-their-lowest-level-in-over-10-years-here-is-why-8415271?utm_campaign=quote-yahoo&utm_source=yahoo&utm_medium=referral
[2] Bill McColl. (November 2, 2023). Moderna Shares Slide After Posting a Loss on Falling COVID-19 Vaccine Sales and Production. Retrieved from https://www.investopedia.com/moderna-posts-steep-loss-amid-falling-vaccine-demand-production-cuts-8386588
[3] Florian Krammer. (October 2, 2023). The Future Of COVID-19 Vaccine Development. Retrieved from https://www.healthaffairs.org/content/forefront/future-covid-19-vaccine-development
[4] Spencer Kimball. (January 31, 2023). The Covid pandemic drives Pfizer’s 2022 revenue to a record $100 billion. Retrieved from
Last updated: 15 December 2023
2023-12-15 11:01:16
#future #COVID19 #vaccines #day #world #recovers #epidemic #Investing #Science #Investerest.co
